SYRA — Who's Buying and Selling (13F)

Syra Health Corp held its annual meeting on July 23, 2026, and shareholders approved all three proposals. All five director nominees — including Priya, Radhika, and three others listed only as “Dr.” — were elected. The appointment of M&K CPAs as auditor was ratified overwhelmingly. Shareholders also approved an amendment to the 2022 Omnibus Equity Incentive Plan, raising the cap on Class A shares available for issuance to 4,100,000 (with about 2.69 million votes against and 2.42 million broker non-votes).